Prime Minister Justin Trudeau says a deal has been struck with Novavax to produce its COVID-19 vaccine in Canada, but the pharmaceutical company won’t be ready to roll out doses for several months.
The federal government has signed a “memorandum of understanding” with Novavax to pursue options to produce its COVID-19 vaccine at a new Montreal facility that is under constructions growing daily..
While the prime minister is calling this a “major step forward,” it could be months before this potential first made-in-Canada vaccine candidate is approvedis allowed, transit and ferries will increase their services as required., let alone shipped to delivery sites nationwide. This is because the new National Research Council biomanufacturing facility where the production will happen isn’t set to be completed until July.
Once the new facility is up and running, it’s designed to produce around two million doses a month andat a time that Canada had administered fewer than 2.5 million doses., should the Novavax vaccine be deemed safe and effective, Trudeau says “tens of millions” of doses will be made domestically. The facility will not be able to produce MRNA vaccinesThere are 1,052,539 confirmed cases in Canada., however, which are the kind of vaccines Pfizer-BioNTech and Moderna are supplying.
Copyright © 2011 JIN SHI